Segall Bryant & Hamill’s QuidelOrtho QDEL Stock Holding History

Segall Bryant & Hamill’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.6M	Sell	1,345,530 -197,880	-13%	-$2.61M	0.28%	114
2026 Q1	$25.4M	Buy	1,543,410 +348,549	+29%	+$8.56M	0.36%	80
2025 Q4	$34.1M	Sell	1,194,861 -34,291	-3%	-$929K	0.46%	57
2025 Q3	$36.2M	Sell	1,229,152 -71,044	-5%	-$1.94M	0.48%	51
2025 Q2	$37.5M	Buy	1,300,196 +11,478	+0.9%	+$339K	0.53%	42
2025 Q1	$45.1M	Buy	1,288,718 +242,069	+23%	+$9.87M	0.69%	19
2024 Q4	$46.6M	Buy	1,046,649 +617,592	+144%	+$25.3M	0.64%	28
2024 Q3	$19.6M	Buy	+429,057	New	+$17.4M	0.27%	119

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Segall Bryant & Hamill's QDEL Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its QuidelOrtho (QDEL) stake by 13% in Q2 2026, selling an estimated $2.61M and leaving 1,345,530 shares worth $23.6M. The position accounts for 0.28% of the portfolio, ranked #114.

Segall Bryant & Hamill first reported a position in QDEL in Q3 2024 and has held it in 8 quarters since. The position peaked at $46.6M in Q4 2024. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

Segall Bryant & Hamill held 1,345,530 shares of QuidelOrtho worth $23.6M as of Q2 2026.
Segall Bryant & Hamill sold 197,880 QuidelOrtho shares in Q2 2026, an estimated $2.61M.
QuidelOrtho made up 0.28% of Segall Bryant & Hamill's portfolio in Q2 2026, its #114 holding.
Segall Bryant & Hamill first reported a position in QuidelOrtho in Q3 2024 and has held it in 8 quarters since.
Segall Bryant & Hamill's QuidelOrtho position peaked at $46.6M in Q4 2024.
246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.